Skip to main content

LifeStance Health Group Inc

For the period ended Mar 31, 2024. Filed May 9, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 9, 2024

LFST$14.60+6.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Changes in Stockholders' Equity

(In thousands)

Common Stock · AdditionalPaid-in · Accumulated Other Comprehensive · Accumulated · Total Stockholders'
SharesAmountCapitalIncomeDeficitEquity
Balances at December 31, 2023378,725$3,789$2,183,684$2,303$(760,846)$1,428,930
Net loss————(21,097)(21,097)
Issuance of common stock upon vesting of restricted stock units5,68756(56)———
Forfeitures(2,307)(24)24———
Other comprehensive income———583—583
Stock-based compensation expense——20,581——20,581
Balances at March 31, 2024382,105$3,821$2,204,233$2,886$(781,943)$1,428,997
Common Stock · AdditionalPaid-in · Accumulated Other Comprehensive · Accumulated · Total Stockholders'
SharesAmountCapitalIncomeDeficitEquity
Balances at December 31, 2022375,964$3,761$2,084,324$3,274$(572,636)$1,518,723
Net loss————(34,242)(34,242)
Adoption of ASU 2016-13————(1,948)(1,948)
Issuance of common stock upon vesting of restricted stock units1,71117(17)———
Forfeitures(1,138)(11)(3,354)——(3,365)
Other comprehensive loss———(1,270)—(1,270)
Stock-based compensation expense——27,231——27,231
Balances at March 31, 2023376,537$3,767$2,108,184$2,004$(608,826)$1,505,129
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.